Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
The plant will have installed production capacity of 3,120 MT/month
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
Multi-year collaboration focuses on development of biodegradable antimicrobial peptides with broad application possibilities in the areas of skin care and healthcare
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Allam was serving recently as the CEO at Public Investment Fund
Subscribe To Our Newsletter & Stay Updated
